Articles
Volume 12 Supplement 4
Optimizing the use of carbapenems in the face of increasing Gram-negative resistance
Reviews
Edited by Stephan Harbarth
Publication of this supplement has been sponsored by Ortho-McNeil, Inc.
|
Introduction
Optimizing the use of carbapenems in the face of increasing Gram-negative resistance Reuben Ramphal Critical Care 2008, 12(Suppl 4):S1 (21 May 2008) |
|
Review
Pharmacodynamic optimization of β-lactams in the patient care setting David P Nicolau Critical Care 2008, 12(Suppl 4):S2 (21 May 2008) |
|
Review
An overview of harms associated with β-lactam antimicrobials: where do the carbapenems fit in? Robert C Owens Critical Care 2008, 12(Suppl 4):S3 (21 May 2008) |
|
Review
Gram-negative antibiotic resistance: there is a price to pay Thomas G Slama Critical Care 2008, 12(Suppl 4):S4 (21 May 2008) |
|
Review
The role of carbapenems in initial therapy for serious Gram-negative infections James J Rahal Critical Care 2008, 12(Suppl 4):S5 (21 May 2008) |
